Xvivo Perfusion
(OTC: XVIPY)
|
6:02 PM UTC, 07/02/24 | |||
---|---|---|---|---|
Last: $9.81 | Change: -0.56 | %Change: -5.45% | Volume: 100 |
Open: | $ 9.81 | Volume: | 100 | |
---|---|---|---|---|
High: | $ 9.81 | Yield(%) | 0.00 | |
Low: | $ 9.81 | P/E Ratio (ttm): | 127.20 | |
Dividend ($): | n/a | Market Cap ($): | 1.21B | |
EPS ($) | 0.08 | Shares Out: | 126.00M |
% Price Change (last 4 weeks): | -7.06 |
---|---|
% Price Change (last 13 weeks): | 54.65 |
% Price Change (last 26 weeks): | 18.47 |
% Price Change (last 52 weeks): | 41.49 |
% Price Change (year to date): | 17.69 |
Return on Equity (%): | 5.24 |
---|---|
Return on Assets (%): | 4.50 |
Return on Invested Capital (%): | 0.59 |
Gross Profit Margin (%): | 69.77 |
---|---|
Net Profit Margin (%): | 15.37 |
Operating Profit Margin (%): | 6.44 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $10.38 |
52-wk low: | $6.24 |
Bid: | $n/a |
Ask: | $n/a |
Xvivo Perfusion AB is a medical technology company. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. It operates through the Durable Goods and Non-Durable Goods segments. The Durable Goods segment includes sales and rental revenues from machines. The Non-Durable Goods segment covers sales of goods and services that are not durable goods. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.
|
Xvivo Perfusion
Mässans gata 10 Gothenburg VG 412 51 Phone: 46.31.788.21.50 Fax: 46.31.788.21.69 http://www.xvivoperfusion.com |
Earnings (1year) ($): | 0.08 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | 127.20 |
Book Value ($): | 1.53 |
Cash Flow ($): | 0.09 |
Price/Earnings (x): | 127.20 |
---|---|
Price/Sales (x): | 17.39 |
Price/Book (x): | 5.34 |
Price/Cash Flow (x): | 224.48 |
Quick Ratio (x): | 5.09 |
---|---|
Current Ratio (x): | 6.14 |
LT Debt/Equity (x): | 1.09 |
Total Debt/Equity (x): | 1.62 |